Abbott deal highlights inversion inaction

Share this article:

Political furor over the recent spate of tax inversions is having little influence on how the government chooses its partners. Crain's Chicago Business says the recent $19.5 billion Defense Department deal with Abbott to develop brain injury diagnostics shows that anger about changing an address to avoid taxes amounts to little more than posturing.

Reporter Joe Cahill notes that although Abbott has not inverted (it has used a "spinversion" to achieve a similar result with its Mylan deal creating a freestanding off-shore business interest which does not have to tangle with US tax requirements), the DOD could have opted not to contract with a company that is looking for US business benefits without paying for them.

Cahill writes that President Barack Obama “conceivably could order federal agencies to shun companies that reincorporate overseas for tax purposes. That would be a dramatic step.”

There have been proposals to deter inversions, such as one by Treasury Secretary Jacob Lew,  to discourage relocations in which the tax address changes but the staff does not. Such efforts may not make much of a dent: a defense industry analyst tells Crain's that the fuss currently amounts to noise, because contracts are granted based on the best prices, product performance, and compliance with procurement rules.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.